Carlos Labat
Impact in
- Aging top 0.2%
- Genetics, Aging, and Longevity in Model Organisms
-
- Cardiovascular Health and Disease Prevention
- Blood Pressure and Hypertension Studies
- Heart Rate Variability and Autonomic Control
Papers in
- Aging 6
- Physiology 67
- Asthma and respiratory diseases 26
- Telomeres, Telomerase, and Senescence 24
- Nitric Oxide and Endothelin Effects 10
- Co-authors
- Athanase BénétosAbraham AvivMasayuki KimuraMichel E. SafarPatrick LacolleyFrédérique ThomasPaolo SalviXavier Norel
- Journals
- Journal of Hypertension (17 papers)British Journal of Pharmacology (12 papers)Hypertension (11 papers)Journal of Pharmacology and Experimental Therapeutics (8 papers)American Journal of Hypertension (6 papers)
- Partner nations
- FranceUnited StatesItaly
In The Last Decade
Carlos Labat
138 papers receiving 6.3k citations
Hit Papers
Peers
Comparison fields: 5 of 139
- Aging 594
- Cardiology and Cardiovascular Medicine 2.4k
- Physiology 2.7k
- Endocrinology, Diabetes and Metabolism 750
- Geriatrics and Gerontology 168
Countries citing papers authored by Carlos Labat
This map shows the geographic impact of Carlos Labat's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Carlos Labat with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Carlos Labat more than expected).
Fields of papers citing papers by Carlos Labat
This network shows the impact of papers produced by Carlos Labat. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Carlos Labat. The network helps show where Carlos Labat may publish in the future.
Co-authors
The 25 scholars most cited alongside Carlos Labat, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2022 | 10 | |
| 2 | 2022 | 5 | |
| 3 | 2021 | 26 | |
| 4 | 2020 | 3 | |
| 5 | 2017 | 36 | |
| 6 | 2014 | 26 | |
| 7 | 2013 | 34 | |
| 8 | 2013 | 3 | |
| 9 | 2012 | 115 | |
| 10 | 2012 | 16 | |
| 11 | 2010 | 124 | |
| 12 | 2010 | 173 | |
| 13 | 2009 | 41 | |
| 14 | 2008 | 47 | |
| 15 | 2005 | 24 | |
| 16 | 2004 | 18 | |
| 17 | 2000 | 1 | |
| 18 | 1999 | 18 | |
| 19 | 1988 | 20 | |
| 20 | 1987 | 36 |
About Carlos Labat
Carlos Labat is a scholar working on Aging, Physiology, Cardiology and Cardiovascular Medicine, Endocrinology, Diabetes and Metabolism and Pulmonary and Respiratory Medicine, having authored 141 papers that have together received 6.5k indexed citations. Recurring topics across this work include Cardiovascular Health and Disease Prevention (34 papers), Asthma and respiratory diseases (26 papers), Telomeres, Telomerase, and Senescence (24 papers), Blood Pressure and Hypertension Studies (22 papers), Respiratory and Cough-Related Research (14 papers), Hormonal Regulation and Hypertension (11 papers), Cardiovascular, Neuropeptides, and Oxidative Stress Research (10 papers) and Nitric Oxide and Endothelin Effects (10 papers). The work is most often cited by research in Aging (594 citations), Cardiology and Cardiovascular Medicine (2.4k citations), Physiology (2.7k citations), Endocrinology, Diabetes and Metabolism (750 citations) and Geriatrics and Gerontology (168 citations). Carlos Labat has collaborated with scholars based in France, United States and Italy. Frequent co-authors include Athanase Bénétos, Abraham Aviv, Masayuki Kimura, Michel E. Safar, Patrick Lacolley, Frédérique Thomas, Paolo Salvi, Xavier Norel, K. Bean and Charles Brink. Their work appears in journals such as Journal of Hypertension, British Journal of Pharmacology, Hypertension, Journal of Pharmacology and Experimental Therapeutics and American Journal of Hypertension.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.